Results 261 to 270 of about 1,736,474 (279)

A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen

International Journal of Cancer, 2011
Kazuhiro Kakimi, Hisashi Wada
exaly  

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1

Cancer Letters, 2006
Martina Sester, Urban Sester, Ugur Sahin
exaly  

The ESO method revisited

Structural and Multidisciplinary Optimization, 2014
Kazem Ghabraie
exaly  

NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis

Modern Pathology, 2012
Phyu Phyu Aung, Chyi-Chia Richard Lee
exaly  

NY-ESO-1 protein expression in primary breast carcinoma and metastases—correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration

International Journal of Cancer, 2007
Alfred Zippelius, Zsuzsanna Varga, Burkhardt Seifert   +2 more
exaly  

Model Free ESO-Based Repetitive Control for Rejecting Periodic and Aperiodic Disturbances

IEEE Transactions on Industrial Electronics, 2017
Zhenwei Cao, Zhihong Man
exaly  

Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432

Vaccine, 2009
Hiroyoshi Nishikawa, Hiroaki Ikeda, Kyosuke Tanaka   +2 more
exaly  

ESO expands

Physics Bulletin, 1981
openaire   +1 more source

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™

Cancer Immunology, Immunotherapy, 2011
Weisan Chen, Ian D Davis, Eugene Maraskovsky   +2 more
exaly  

Esos Cerros

2023
openaire   +1 more source